Our news

Do you want to receive our media releases and be among the first to learn about our news and innovations?

Contact us

Media releases

New President of Nobel Biocare announced

Jul 18, 2024

Nobel Biocare’s new president has been announced by Envista Holdings Corporation as Mr. Stefan Nilsson.

Most recently, Mr.

Nobel Biocare partnered with Mimetis Biomaterials S.L. and launches creos™ syntogain, biomimetic bone graft substitute.

Jan 30, 2023

creos™ syntogain joins creos™ syntoprotect, creos™ xenoprotect, creos™ xenogain and creos™ mucogain to establish Nobel Biocare as the supplier of choice for organic or synthetic regeneration need.

Patrik Eriksson (Left), President of Nobel Biocare, presented the trophy to Dr. Paulo Malo (Right)

Nobel Biocare awards Dr. Paulo Malo for 25 years of the All-on-4® treatment concept

Jan 16, 2023

Dr. Paulo Malo has been presented a Quarter Century Award from Nobel Biocare, honoring the twenty-fifth anniversary of the revolutionary All-on-4® treatment concept. At a gathering in Nobel Biocare’s Dental Experience Center in Zurich, Switzerland, company President, Patrik Eriksson presented the trophy.

Nobel Biocare and Boston University announce philanthropic partnership

Jul 14, 2022

Boston, Massachusetts. Today, Nobel Biocare and Boston University agreed to a 10-year philanthropic partnership, effective July 1, 2022.

Nobel Biocare Symposium to return as part of the new Envista Summit in Vienna

Jun 07, 2022

The acclaimed Nobel Biocare Symposium returns afresh in a new format, as the Implant Track at the Envista Summit, hosted by Nobel Biocare’s parent company Envista.

Nobel Biocare ventures into synthetic-membrane technology to further expand regenerative portfolio

Mar 31, 2022

Nobel Biocare has made a key addition to the creos™ regenerative portfolio, introducing its first synthetic membrane, creos™ syntoprotect.

Implant dentistry enters new era with launch of Nobel Biocare Xeal™ and TiUltra™ surfaces in the United States

Jan 12, 2021

Nobel Biocare invites dental professionals to join the Mucointegration™ era with the launch of the Xeal and TiUltra surfaces in the United States. These new surfaces are applied to implants and abutments, which optimizes tissue integration at every level.

Nobel Biocare and DOCERAM Medical Ceramics announce expanded partnership in premium restorative solutions

Nov 03, 2020

Nobel Biocare and DOCERAM Medical Ceramics are combining their strengths to offer more high-quality restorative solutions, and with ease and flexibility for customers in mind.

Nobel Biocare Global Symposium virtual edition breaks registration record with over 10,000 participants

Apr 21, 2020

With more than 10,000 unique registrations, the online edition of Nobel Biocare Global Symposium brought by Envista was not only an extraordinary educational event but also an example of how remote teams can quickly adapt to unprecedented circumstances.

Nobel Biocare receives EU Medical Device Regulation Quality Management Certificate

Apr 20, 2020

Nobel Biocare is pleased to announce the receipt of the EU Medical Device Regulation (MDR) Quality Management System certification by its Notified Body, the BSI Group, the Netherlands B.V. This signifies that Nobel Biocare’s Quality Management System, and the corresponding first group of products, meet the requirements of the new MDR implemented by the European Union.

Envista announces the Nobel Biocare Global Symposium 2020 in Las Vegas

Dec 19, 2019

Envista is proud to announce the Nobel Biocare Global Symposium 2020, to be held in Las Vegas, April 16 – 18. Empowered by a combination of expert knowledge and innovative solutions that are elevating patient care, the event will be a unique opportunity for dental professionals to explore the future of dental implantology and digital dentistry.

Full supplement of CIDRR highlights scientific evidence for Nobel Biocare’s latest surface innovations

Jun 28, 2019

With the launch of its Xeal™ abutment surface and TiUltra™ implant surface this year, Nobel Biocare recently initiated the Mucointegration™ era for implant dentistry. Now, evidence supporting these pioneering surfaces including clinical data has become available in a special supplement of the journal Clinical Implant Dentistry and Related Research (CIDRR).

Media contact

Email: media.relations@nobelbiocare.com

Our news

Media releases

Nobel Biocare’s new president has been announced by Envista Holdings Corporation as Mr. Stefan Nilsson.

Media contact

Sign up for our blog update